We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
-0.79%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$66.5M
Cap. Flow
+$88.3M
Cap. Flow %
4.89%
Top 10 Hldgs %
26.09%
Holding
383
New
16
Increased
149
Reduced
137
Closed
11

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.38%
2 Technology 15.48%
3 Financials 10.25%
4 Healthcare 9.64%
5 Consumer Staples 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTAK icon
351
Catheter Precision
VTAK
$724K
$215K 0.01%
7
VSGX icon
352
Vanguard ESG International Stock ETF
VSGX
$6.82B
$214K 0.01%
3,468
+145
+4% +$9.25K
IUSG icon
353
iShares Core S&P US Growth ETF
IUSG
$33.5B
$212K 0.01%
2,073
DLR icon
354
Digital Realty Trust
DLR
$68.8B
$211K 0.01%
+1,463
New +$229K
DUK icon
355
Duke Energy
DUK
$93.8B
$210K 0.01%
+2,147
New +$222K
TWTR
356
DELISTED
Twitter, Inc.
TWTR
$207K 0.01%
3,434
+379
+12% +$24.9K
CHD icon
357
Church & Dwight Co
CHD
$24B
$206K 0.01%
2,499
FAST icon
358
Fastenal
FAST
$57.1B
$206K 0.01%
7,982
-116
-1% -$3.15K
IYF icon
359
iShares US Financials ETF
IYF
$4.31B
$204K 0.01%
2,470
SCHP icon
360
Schwab US TIPS ETF
SCHP
$16.5B
$204K 0.01%
6,512
VCYT icon
361
Veracyte
VCYT
$3.48B
$204K 0.01%
4,400
-4,400
-50% -$192K
NAC icon
362
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
$182K 0.01%
+11,588
New +$184K
GRFS
363
Grifois
GRFS
$5.23B
$160K 0.01%
10,955
-14
-0.1% -$212
TCON
364
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$157K 0.01%
2,023
IEZ icon
365
iShares US Oil Equipment & Services ETF
IEZ
$386M
$137K 0.01%
10,000
SRTA
366
Strata Critical Medical Inc
SRTA
$528M
$104K 0.01%
10,000
ADMS
367
DELISTED
Adamas Pharmaceuticals
ADMS
$79K ﹤0.01%
16,000
FBIO icon
368
Fortress Biotech
FBIO
$92.4M
$64K ﹤0.01%
1,333
SIRI icon
369
SiriusXM
SIRI
$9.62B
$63K ﹤0.01%
+1,030
New +$64.7K
GERN icon
370
Geron
GERN
$970M
$53K ﹤0.01%
39,047
STAB
371
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$34K ﹤0.01%
+14,675
New +$55.6K
RGLS
372
DELISTED
Regulus Therapeutics
RGLS
$8K ﹤0.01%
1,200
ALL icon
373
Allstate
ALL
$65.9B
-1,548
Closed -$202K
DOW icon
374
Dow Inc
DOW
$22B
-3,393
Closed -$215K
EMN icon
375
Eastman Chemical
EMN
$8.35B
-1,807
Closed -$211K

Similar funds

Dowling & Yahnke's Q3 2021 Portfolio in Review

As of Q3 2021, Dowling & Yahnke held 383 positions worth $1.81B, up 3.8% from $1.74B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke deployed $88.3M of net new capital in Q3 2021, opening 16 new positions and adding to 149 existing holdings. Its largest new stake was Dimensional International Value ETF: 872,496 shares worth $28.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Semiconductor ETF, an estimated $1.28M trimmed.

  • Dowling & Yahnke's largest Q3 2021 buy was Dimensional International Value ETF: 872,496 shares worth $28.6M.
  • Dowling & Yahnke added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $13.7M increase.
  • Dowling & Yahnke's biggest Q3 2021 reduction was iShares Semiconductor ETF, cutting an estimated $1.28M.
  • Dowling & Yahnke fully exited Uber in Q3 2021, selling an estimated $864K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $1.81B portfolio in Q3 2021.
  • Dowling & Yahnke opened 16 new positions and closed 11 in Q3 2021.
  • Dowling & Yahnke's portfolio value rose 3.8% quarter-over-quarter to $1.81B.

Based on Dowling & Yahnke's 13F filing for Q3 2021, filed 12 Nov 2021.